1. Home
  2. EVH vs CERS Comparison

EVH vs CERS Comparison

Compare EVH & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

N/A

Current Price

$3.03

Market Cap

344.8M

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

N/A

Current Price

$1.70

Market Cap

276.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
EVH
CERS
Founded
2011
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
EDP Services
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
344.8M
276.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
EVH
CERS
Price
$3.03
$1.70
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$7.93
N/A
AVG Volume (30 Days)
3.1M
1.8M
Earning Date
05-20-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
$907,957,000.00
$51,326,000.00
Revenue This Year
$33.03
$20.00
Revenue Next Year
$16.03
$9.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$2.50
$1.12
52 Week High
$11.92
$2.96

Technical Indicators

Market Signals
Indicator
EVH
CERS
Relative Strength Index (RSI) 45.28 31.21
Support Level $2.53 $1.27
Resistance Level $4.20 $1.72
Average True Range (ATR) 0.27 0.16
MACD 0.01 -0.08
Stochastic Oscillator 43.10 7.55

Price Performance

Historical Comparison
EVH
CERS

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: